Atrium Withdraws Some Catheters For Heparin Fears

Law360, New York (May 13, 2008, 12:00 AM EDT) -- Following in the footsteps of Medtronic Inc., Atrium Medical Corporation has decided to recall a heparin-coated product as the fallout from tainted batches of the blood thinner continues.

On Monday, Atrium revealed the “voluntary and precautionary” move, calling back selected lots of Hydraglide brand heparin-coated thoracic drainage catheters that are used during cardiopulmonary bypass surgery.

“While Atrium’s Hydraglide catheters do not contain high levels of heparin, there still exists a potential exposure of oversulfated chondroitin sulfate (OSCS) to the patient,” the company said.

Though the patient...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.